Neuroendocrine tumors (NETs) are a heterogenous group of tumors that originate from
neuroendocrine cells, mainly in the pancreas and the gastrointestinal and …

Introduction Pancreatic neuroendocrine tumors (PNETs) in hereditary syndromes pose a
significant challenge to clinicians. The rarity of these syndromes and PNETs itself make it …

Simple Summary Pancreatic neuroendocrine tumors are composite entities due to their
heterogeneity illustrated in clinical behavior, mutational pattern, and site of origin. Pancreatic …

Pancreatic neuroendocrine tumors (pNETs) are characterized as a rare disease with an
incidence of less than 1 in 100,000 individuals per year, and accounts for 1% to 2% of all …

Introduction: Pancreatic neuroendocrine tumors (pNETs) represent a small part of pancreatic
neoplasms, and the knowledge about their indolent clinical course remains a subject of …

Pancreatic neuroendocrine tumors (pNETs) are a group of heterogeneous tumors originated
from progenitor cells. As these tumors are predominantly non-functional, most of them …

Pancreatic neuroendocrine tumors (PNETs), which account for 1% to 2% of all pancreatic
neoplasms, are pathologically heterogeneous and consist of epithelial cells with phenotypic …

Pancreatic neuroendocrine tumors (PanNETs) are a common and deadly neoplasm of the
pancreas. Although the importance of genetic alterations in PanNETs has been known for …

Here we report the DNA methylation profile of 84 sporadic pancreatic neuroendocrine
tumors (PanNETs) with associated clinical and genomic information. We identified three …

Molecular profiling of GEP-NETs demonstrates that pancreatic endocrine tumors and
gastrointestinal neuroendocrine tumors (carcinoids) display different genetic changes and …